William Clearfield, a graduate of LaSalle College and the College of Osteopathic Medicine and Surgery, Des Moines, IA., completed a rotating internship and served as an OB/GYN resident at Metropolitan Hospital, Philadelphia, PA
If youd like to gain access to our GLP-1 reports, or want to hear more about our platform as a whole, please reach out to [email protected].
For example, use of a GLP-1 cut a patient's odds of kidney failure by 16% and a worsening of their kidney function by 22%, Budve and team reported
If Novo Nordisk demonstrates adequate supply and the FDA removes semaglutide from the shortage list, the legal framework for compounding it narrows significantly, similar to what has already happened with tirzepatide